AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (1202)	3/3/1998 7:06:00 PM
From: jbershad	Read Replies (2) of 2173

Prof. Henry A couple of things. The situation for AMLN is very serious. They may run out of money. Are some competitive products to treat type II diabetes one from Ergo who J&J has chosen as a new partner and another from WLA better than AMLN's. I think they compliment it. You know alot. I and the other people on the thread would appreciate your giving a good post on this. The bad news you post does nobody good. AMLN's problems appears to be in the dosing. I will hold the stock and see what happens at these levels. I don't feel bad because i have had stocks in the last two years that have more than tripled. I also own LGND at 10. Nobody can be perfect. Jerry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next